InformedCitizen.usBeta
Passed the House

To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.

H.R. 2319 · House bill · Introduced March 25, 2025

No plain-language summary yet.

At a glance

Who it affects

  • Not yet summarized

Where it stands

Passed the House

Lobbying and money

No lobbying reported yet

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

What it would do

No plain-language summary yet.

How South Carolina voted

No recorded roll-call vote on this bill yet.

Groups that lobbied on it and gave to SC's members

PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.

No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

Official record

Official title, sponsor and status
Official title
To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
Sponsor
Rep. Boyle, Brendan F. (D-PA)
Introduced
March 25, 2025
Cosponsors
2
Committees
House Energy and Commerce Committee
Latest action
April 22, 2026 · Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Congress.gov ↗
Official summary from the Congressional Research Service

Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.

Summary on Congress.gov ↗
Everyone who lobbied on this bill (0 groups)

No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.